Hong-Sin Kim
Vorsitzender bei Korea Stem Cell Bank Co., Ltd.
Profil
Hong-Sin Kim is currently the Chairman of Korea Stem Cell Bank Co., Ltd.
and a Professor at Konkuk University.
In the past, he served as an Independent Director at ChoA Pharmaceutical Co., Ltd.
and BIOVILL Co., Ltd.
from 2012 to 2018.
Aktive Positionen von Hong-Sin Kim
Unternehmen | Position | Beginn |
---|---|---|
Konkuk University | Corporate Officer/Principal | - |
Korea Stem Cell Bank Co., Ltd.
Korea Stem Cell Bank Co., Ltd. BiotechnologyHealth Technology Korea Stem Cell Bank Co., Ltd. develops stem cell storage and treatment technology solutions. It also engages in the research and development of stem cell therapies to treat various diseases, including cancers, chronic, and incurable diseases. The company was founded on December 20, 2005 and is headquartered in Seongnam-si, South Korea. | Vorsitzender | - |
Ehemalige bekannte Positionen von Hong-Sin Kim
Unternehmen | Position | Ende |
---|---|---|
KSCB CO LTD | Vorsitzender | - |
CHOA PHARMACEUTICAL CO., LTD. | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
CHOA PHARMACEUTICAL CO., LTD. | Health Technology |
Private Unternehmen | 2 |
---|---|
BIOVILL Co., Ltd.
BIOVILL Co., Ltd. Industrial SpecialtiesProcess Industries BIOVILL Co., Ltd. engages in the manufacture and sale of functional materials. Its products include coloring materials for plastics, inks for plastic printing, surface treatment materials, polyvinyl compound, frame structure, and other products. The company was founded in April 1976 and is headquartered in Yangsan-si, South Korea. | Process Industries |
Korea Stem Cell Bank Co., Ltd.
Korea Stem Cell Bank Co., Ltd. BiotechnologyHealth Technology Korea Stem Cell Bank Co., Ltd. develops stem cell storage and treatment technology solutions. It also engages in the research and development of stem cell therapies to treat various diseases, including cancers, chronic, and incurable diseases. The company was founded on December 20, 2005 and is headquartered in Seongnam-si, South Korea. | Health Technology |